ACLY and hepatocellular carcinoma: Further analyses of lipid-metabolism enzymes in sorafenib-resistant hepatoma cells showed that ACLY, ACC and FASN were activated to varying degrees, especially ACLY expression, which suggested that ACLY may play an important part in the sorafenib resistance of HCC15.